<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="85597">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01811550</url>
  </required_header>
  <id_info>
    <org_study_id>11110979</org_study_id>
    <secondary_id>1U01NS079077-01A1</secondary_id>
    <nct_id>NCT01811550</nct_id>
  </id_info>
  <brief_title>Study of Procoagulation Markers in Stroke Patients</brief_title>
  <acronym>I-SPOT</acronym>
  <official_title>Insights on Selected Procoagulation Markers and Outcomes in Stroke Trial (I-SPOT)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Temple University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Neurological Disorders and Stroke (NINDS)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>SHINE Trial</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Neurological Emergencies Treatment Trials Network (NETT)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Virginia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Michigan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Medical University of South Carolina</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Georgia Regents University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Temple University</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <authority>United States: Data and Safety Monitoring Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Insights on Selected Procoagulation Markers and Outcomes in Stroke Trial (I-SPOT):
      Response to Insulin Administration and Blood Glucose Control proposal is designed to
      accompany the Stroke Hyperglycemia Insulin Network Effort (SHINE) clinical trial, a Phase
      III multicenter, randomized, controlled trial planning to determine the efficacy and
      validate the safety of glycemic control in stroke patients. The SHINE trial will recruit
      1,400 AIS patients with Type II diabetes mellitus (T2DM) and hyperglycemia, each receiving 3
      days of hyperglycemia control with intravenous (IV) insulin therapy or control therapy with
      subcutaneous (SQ) insulin. The I-SPOT trial will recruit 315 SHINE patients.  Blood
      coagulation marker levels will be measured before and at 48 hours after the start of
      treatment. Baseline and temporal changes in biomarkers levels will be compared between
      treatment groups.

      Hypothesis: The decrease in levels of markers of blood coagulation will be greater in
      patients treated with IV insulin to reduce BG than in patients treated with SQ Insulin as
      the standard fashion.

      Hypothesis: The decrease in levels of markers of blood coagulation will be  greater in
      patients with than without favorable (SHINE) outcome (defined as  the baseline stroke
      severity adjusted measure of functional ability at 90 days  after AIS).

      Hypothesis: Hyperglycemia control modulates the relationship between blood  coagulation
      levels and functional outcome in T2DM patients after stroke.  Patients treated with IV
      Insulin for hyperglycemia control with favorable  (SHINE) outcome will have greater
      decreases in blood coagulation levels  than either IV Insulin-treated patients without
      favorable outcome or SQ Insulin-treated with or without favorable outcomes at 90 days after
      AIS.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2012</start_date>
  <primary_completion_date type="Anticipated">August 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>change in biomarker between patients with favorable versus unfavorable functional outcome</measure>
    <time_frame>Randomization, 48 hours and 90 days</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in biomarker levels between patients with versus without stroke recurrence at 90 days post stroke.</measure>
    <time_frame>Randomization, 48 hours, 90 days</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">315</enrollment>
  <condition>Stroke</condition>
  <condition>Hyperglycemia</condition>
  <condition>Procoagulation Markers</condition>
  <arm_group>
    <arm_group_label>SHINE study subjects</arm_group_label>
    <description>Subjects enrolled in the SHINE trial who are not recieving thrombolytics nor systemic anticoagulation; have no known moderate/severe hepatic insufficiency; have no known history of hypercoaguable or thrombotic condition; have INR =&lt;1.5 (if known) at baseline and provide informed consent (self or LAR) will be enrolled in the I-SPOT study.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Glycemic Control</intervention_name>
    <arm_group_label>SHINE study subjects</arm_group_label>
    <other_name>Blood draw at 0 and 48 hours</other_name>
    <other_name>Glycemic Control per SHINE protocol</other_name>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Whole blood and plasma
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects will be selected from subjects participating in the SHINE trial.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Enrolled in SHINE study

          -  Ability to give Informed Consent (self or LAR)

        Exclusion Criteria:

          -  Current or anticipated use of systemic anticoagulants or thrombolytics

          -  Known moderate or severe hepatic insufficiency (as defined by INR&gt;1.5 if     known or
             history of variceal bleeding or hepatic encephalopathy)

          -  Prior or concurrent thrombotic or hypercoagulable condition (Antiphospholipid
             antibody syndrome; Antithrombin III, Protein C or S deficiencies; Congenital or
             Inherited Factor deficiencies; sickle cell disease)
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nina T Gentile, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Temple University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hannah Reimer, RN, BSN</last_name>
    <phone>215-707-5483</phone>
    <email>hreimer@temple.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Ronald Regan Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90095</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ileana Grunberg</last_name>
      <email>igrunberg@mednet.ucla.edu</email>
    </contact>
    <investigator>
      <last_name>Sidney Starkman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stanford University Medical Center</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ryan Snider</last_name>
      <email>rsnider@stanford.edu</email>
    </contact>
    <investigator>
      <last_name>James Quinn, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic Jacksonville</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32224</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sothear Luke</last_name>
      <email>luke.sothear@mayo.edu</email>
    </contact>
    <investigator>
      <last_name>Kevin Barrett, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Grady Memorial Hospital</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Alex Hall</last_name>
      <email>alex.hall@emory.edu</email>
    </contact>
    <investigator>
      <last_name>Vishal Patel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Georgia Health Sciences University</name>
      <address>
        <city>Augusta</city>
        <state>Georgia</state>
        <zip>30912</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Brian Close</last_name>
      <email>bclose@georgiahealth.edu</email>
    </contact>
    <investigator>
      <last_name>Askiel Bruno, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Kentucky</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <zip>40506</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Linda Dechtenberg</last_name>
      <email>ldech3@email.uky.edu</email>
    </contact>
    <investigator>
      <last_name>Roger Humphries, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Eric Riklin</last_name>
      <email>eriklin@partners.org</email>
    </contact>
    <investigator>
      <last_name>Chris Anderson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Henry Ford Hospital</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne Marie Lundell</last_name>
      <email>ALUNDEL1@hfhs.org</email>
    </contact>
    <investigator>
      <last_name>Chris Lewandowski, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Detroit Receiving Hospital</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Valerie Mika</last_name>
      <email>vmika@med.wayne.edu</email>
    </contact>
    <investigator>
      <last_name>Gregory Norris, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Harper University</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Valerie Mika</last_name>
      <email>vmika@med.wayne.edu</email>
    </contact>
    <investigator>
      <last_name>Robert Welch, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sinai-Grace Hospital</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48235</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Valerie Mika</last_name>
      <email>vmika@med.wayne.edu</email>
    </contact>
    <investigator>
      <last_name>Robert Welch, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>William Beaumont Hospital-Royal Oak</name>
      <address>
        <city>Royal Oak</city>
        <state>Michigan</state>
        <zip>48073</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Megan Hausler</last_name>
      <email>Megan.Hausler@beaumont.edu</email>
    </contact>
    <investigator>
      <last_name>Robert Swor, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>William Beaumont Hospital-Troy</name>
      <address>
        <city>Troy</city>
        <state>Michigan</state>
        <zip>48085</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Blerina Shaqiri</last_name>
      <email>blerina.shaqiri@beaumont.edu</email>
    </contact>
    <investigator>
      <last_name>Aveh Bastani, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Minnesota Medical Center, Fairview</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55455</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Julie Scherber</last_name>
      <email>JScherber@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Mustapha Ezzeddine, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hennepin County Medical Center</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55415</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Julie Scherber</last_name>
      <email>JScherber@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Mustapha Ezzeddine, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hackensack University Medical Center</name>
      <address>
        <city>Hackensack</city>
        <state>New Jersey</state>
        <zip>07601</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Gordon Huie</last_name>
      <email>GHuie@HackensackUMC.org</email>
    </contact>
    <investigator>
      <last_name>Joseph Feldman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kings County Hospital</name>
      <address>
        <city>Brooklyn</city>
        <state>New York</state>
        <zip>11203</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sarah Zelonis</last_name>
      <email>sarah.zelonis@downstate.edu</email>
    </contact>
    <investigator>
      <last_name>Jennifer Martindale, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lincoln Medical and Mental Health Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10451</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Colette Nyajure</last_name>
      <email>Colette.Nyajure@nychhc.org</email>
    </contact>
    <investigator>
      <last_name>Steven Levine, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Columbia University Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Cristina Falo</last_name>
      <email>maf9135@nyp.org</email>
    </contact>
    <investigator>
      <last_name>Stephan Mayer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>NYP Weill Cornell Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Entila Xhori</last_name>
      <email>enx9001@nyp.org</email>
    </contact>
    <investigator>
      <last_name>Halinder Mangat, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Cincinnati</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45221</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Irene Ewing</last_name>
      <email>ewingi@ucmail.uc.edu</email>
    </contact>
    <investigator>
      <last_name>Opeolu Adeoye, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Wexner Medical Center</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>April Spangler</last_name>
      <email>April.Spangler@osumc.edu</email>
    </contact>
    <investigator>
      <last_name>Michel Torbey, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Abington Memorial Hospital</name>
      <address>
        <city>Abington</city>
        <state>Pennsylvania</state>
        <zip>19001</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>David Weisman</last_name>
      <email>dcweisman@gmail.com</email>
    </contact>
    <investigator>
      <last_name>David Weisman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Temple University Hospital</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19140</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hannah Reimer, BSN</last_name>
      <phone>215-707-5483</phone>
      <email>hreimer@temple.edu</email>
    </contact>
    <investigator>
      <last_name>Nina T Gentile, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital of the University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Melissa Kruszewski</last_name>
      <email>ssa.kruszewski@uphs.upenn.edu</email>
    </contact>
    <investigator>
      <last_name>Brett Cucchiara, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Jefferson Hospital</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19102</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jacqueline Urtecho</last_name>
      <email>Jacqueline.Urtecho@jefferson.edu</email>
    </contact>
    <investigator>
      <last_name>Jacqueline Urtecho, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Allegheny General Hospital</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15212</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melissa Tian</last_name>
      <email>MTIAN@wpahs.org</email>
    </contact>
    <investigator>
      <last_name>Crystal Wong</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UPMC - Presbyterian</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15261</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sara DiFiore</last_name>
      <email>vandruffsm@upmc.edu</email>
    </contact>
    <investigator>
      <last_name>Lori Shutter, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UT Southwestern</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Katrina van de Bruinhorst</last_name>
      <email>Katrina.vandebruinhorst@utsouthwestern.edu</email>
    </contact>
    <investigator>
      <last_name>Christiana Hall, MD, MS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Memorial Hermann Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Monica Mendoza-Moore</last_name>
      <email>monica.mendozamoore@uth.tmc.edu</email>
    </contact>
    <investigator>
      <last_name>Elizabeth Jones, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Utah</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84132</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Suyi Nui</last_name>
      <email>SUYI.NIU@hsc.utah.edu</email>
    </contact>
    <investigator>
      <last_name>Jana Wold, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Froedtert Memorial Lutheran Hospital</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53226</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Samantha Gauger</last_name>
      <email>sgauger@mcw.edu</email>
    </contact>
    <investigator>
      <last_name>John Lynch, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Aurora-St. Lukes Hospital</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Tom Aufderheide, MD</last_name>
      <email>taufderh@mcw.edu</email>
    </contact>
    <investigator>
      <last_name>Tom Aufderheide, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2013</verification_date>
  <lastchanged_date>March 18, 2013</lastchanged_date>
  <firstreceived_date>March 12, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hyperglycemia</mesh_term>
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Cerebral Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
